217 related articles for article (PubMed ID: 1640484)
21. Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki67 growth fraction.
Martínez JC; Piris MA; Sánchez-Beato M; Villuendas R; Orradre JL; Algara P; Sánchez-Verde L; Martínez P
J Pathol; 1993 Apr; 169(4):405-12. PubMed ID: 8501537
[TBL] [Abstract][Full Text] [Related]
22. Expression of retinoblastoma protein in human breast cancer: an immunohistochemical study.
Bianchi S; Calzolari A; Giannelli E; Giordano A; Zampi G
Pathologica; 1994 Apr; 86(2):146-9. PubMed ID: 7936756
[TBL] [Abstract][Full Text] [Related]
23. p53 and RB expression predict progression in T1 bladder cancer.
Grossman HB; Liebert M; Antelo M; Dinney CP; Hu SX; Palmer JL; Benedict WF
Clin Cancer Res; 1998 Apr; 4(4):829-34. PubMed ID: 9563875
[TBL] [Abstract][Full Text] [Related]
24. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer.
Pollack A; Wu CS; Czerniak B; Zagars GK; Benedict WF; McDonnell TJ
Clin Cancer Res; 1997 Oct; 3(10):1823-9. PubMed ID: 9815569
[TBL] [Abstract][Full Text] [Related]
25. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
[TBL] [Abstract][Full Text] [Related]
26. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
[TBL] [Abstract][Full Text] [Related]
27. Retinoblastoma protein expression in lung cancer: an immunohistochemical analysis.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R
Oncology; 1994; 51(6):544-51. PubMed ID: 7970501
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
[TBL] [Abstract][Full Text] [Related]
29. Gene discovery in bladder cancer progression using cDNA microarrays.
Sanchez-Carbayo M; Socci ND; Lozano JJ; Li W; Charytonowicz E; Belbin TJ; Prystowsky MB; Ortiz AR; Childs G; Cordon-Cardo C
Am J Pathol; 2003 Aug; 163(2):505-16. PubMed ID: 12875971
[TBL] [Abstract][Full Text] [Related]
30. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors.
Cordon-Cardo C; Zhang ZF; Dalbagni G; Drobnjak M; Charytonowicz E; Hu SX; Xu HJ; Reuter VE; Benedict WF
Cancer Res; 1997 Apr; 57(7):1217-21. PubMed ID: 9102201
[TBL] [Abstract][Full Text] [Related]
31. Prognostic implications of aberrations in p16/pRb pathway in urothelial bladder carcinomas: a multivariate analysis including p53 expression and proliferation markers.
Korkolopoulou P; Christodoulou P; Lazaris A; Thomas-Tsagli E; Kapralos P; Papanikolaou A; Kalliteraki I; Davaris P
Eur Urol; 2001 Feb; 39(2):167-77. PubMed ID: 11223676
[TBL] [Abstract][Full Text] [Related]
32. The molecular basis of cancer suppression by the retinoblastoma gene.
Lee WH
Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
[TBL] [Abstract][Full Text] [Related]
33. Molecular genetic alterations in superficial and locally advanced human bladder cancer.
Presti JC; Reuter VE; Galan T; Fair WR; Cordon-Cardo C
Cancer Res; 1991 Oct; 51(19):5405-9. PubMed ID: 1680549
[TBL] [Abstract][Full Text] [Related]
34. An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma.
Sato K; Moriyama M; Mori S; Saito M; Watanuki T; Terada K; Okuhara E; Akiyama T; Toyoshima K; Yamamoto T
Cancer; 1992 Nov; 70(10):2493-8. PubMed ID: 1358427
[TBL] [Abstract][Full Text] [Related]
35. Altered patterns of retinoblastoma gene product expression in adult soft-tissue sarcomas.
Karpeh MS; Brennan MF; Cance WG; Woodruff JM; Pollack D; Casper ES; Dudas ME; Latres E; Drobnjak M; Cordon-Cardo C
Br J Cancer; 1995 Oct; 72(4):986-91. PubMed ID: 7547254
[TBL] [Abstract][Full Text] [Related]
36. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of retinoblastoma gene inactivation in the spectrum of neuroendocrine lung tumors.
Gouyer V; Gazzéri S; Bolon I; Drevet C; Brambilla C; Brambilla E
Am J Respir Cell Mol Biol; 1998 Feb; 18(2):188-96. PubMed ID: 9476905
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma.
Ioachim E; Charchanti A; Stavropoulos NE; Skopelitou A; Athanassiou ED; Agnantis NJ
Histol Histopathol; 2000 Jul; 15(3):721-7. PubMed ID: 10963116
[TBL] [Abstract][Full Text] [Related]
39. The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells.
Takahashi R; Hashimoto T; Xu HJ; Hu SX; Matsui T; Miki T; Bigo-Marshall H; Aaronson SA; Benedict WF
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5257-61. PubMed ID: 2052605
[TBL] [Abstract][Full Text] [Related]
40. Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: potential synergistic effects on prognosis.
Xu HJ; Cagle PT; Hu SX; Li J; Benedict WF
Clin Cancer Res; 1996 Jul; 2(7):1169-76. PubMed ID: 9816284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
